🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluated the effects of methylphenidate (MPH), a stimulant medi...
Status
Completed
Location
University of the Witwatersrand
Start Date
2023-02-06
Trial ID
NCT07742631
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of omarigl...
Status
Completed
Location
Multiple Locations
Start Date
2012-10-02
Trial ID
NCT01698775
Treatments Being Tested
This is a study to evaluate the safety, tolerability and pharmacokinetics o...
Status
Completed
Location
Atlanta Center for Medical Research - Sickle Cell Subjects Only
Start Date
2020-10-26
Trial ID
NCT04586985
This is a multiple ascending dose study; the purpose of this study is to ex...
Status
Completed
Location
California Clinical Trials
Start Date
2011-10-21
Trial ID
NCT01457339
Treatments Being Tested
The purpose of the study is to assess the effect of the addition of sitagli...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-20
Trial ID
NCT02532855
Purpose. This study will test whether daily Urolithin A (500 mg) for 6 mont...
Status
Enrolling By Invitation
Location
Charles University, Faculty of Medicine in Hradec Kralove
Start Date
2025-10-08
Trial ID
NCT07377136
Treatments Being Tested
This is a phase 1, randomised, first-in-human, double-blinded, placebo-cont...
Status
Completed
Location
CMAX Clinical Research
Start Date
2023-08-24
Trial ID
NCT05946876
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of 2 diffe...
Status
Completed
Location
Multiple Locations
Start Date
2010-06
Trial ID
NCT01106651
Treatments Being Tested
This randomized, double-blind, placebo-controlled, 8-week clinical trial is...
Status
Recruiting
Location
San Francisco Research Institute
Start Date
2026-01-29
Trial ID
NCT07220694
The investigators hypothesize that Nilotinib will be safe in individuals wi...
Status
Completed
Location
Georgetown University Medical Center
Start Date
2017-01
Trial ID
NCT02947893
Treatments Being Tested